Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumors Refractory To Standard Therapy”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Early research (Phase 1)Study completedNCT00816400
What this trial is testing

A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.

Who this might be right for
Cancer
MedImmune LLC 49
Early research (Phase 1)Study completedNCT02225002
What this trial is testing

Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)UnknownNCT04640246
What this trial is testing

Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies

Who this might be right for
CancerTumor, SolidRefractory Cancer
Taiga Biotechnologies, Inc. 60
Early research (Phase 1)Active Not RecruitingNCT05037149
What this trial is testing

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

Who this might be right for
Solid Tumor
Sirnaomics 50
Early research (Phase 1)Looking for participantsNCT06883539
What this trial is testing

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Who this might be right for
Solid Tumor Malignancies, CancerSolid CancersSolid Tumor Cancer+6 more
LaunXP Biomedical Co., Ltd. 24
Early research (Phase 1)Temporarily pausedNCT03120130
What this trial is testing

Study of Amblyomin-X in Advanced Solid Tumor

Who this might be right for
Advanced Cancer
União Química Farmacêutica Nacional S/A 24
Early research (Phase 1)Ended earlyNCT01110083
What this trial is testing

First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
EMD Serono 38
Early research (Phase 1)Study completedNCT04686383
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors

Who this might be right for
Resistant or Refractory Solid Tumors
Calgent Biotechnology Co., Ltd 17
Early research (Phase 1)Ended earlyNCT01581541
What this trial is testing

PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment

Who this might be right for
Solid TumorsLymphoma
National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT01209143
What this trial is testing

Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 52
Early research (Phase 1)Study completedNCT01924689
What this trial is testing

Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

Who this might be right for
Solid Tumor Malignancies
BioMed Valley Discoveries, Inc 24
Early research (Phase 1)Study completedNCT00509613
What this trial is testing

Phase 1 Study With Sorafenib and Sirolimus

Who this might be right for
Advanced Solid TumorRefractory to Standard Therapies
Radboud University Medical Center
Early research (Phase 1)Study completedNCT00949949
What this trial is testing

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

Who this might be right for
Cholangiocarcinoma of the GallbladderLocalized Gallbladder CancerUnresectable Gallbladder Cancer+1 more
Mayo Clinic 38
Early research (Phase 1)Study completedNCT03985072
What this trial is testing

Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor

Who this might be right for
Tumor, SolidGall Bladder CancerCervical Cancer+3 more
Andes Biotechnologies 67
Early research (Phase 1)Study completedNCT00031031
What this trial is testing

Kanglaite Injection Phase I Study

Who this might be right for
Solid Tumors Refractory To Standard TherapyNeoplasms
KangLaiTe USA 16
Early research (Phase 1)Ended earlyNCT01118819
What this trial is testing

Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

Who this might be right for
Solid Tumor Malignancies
BioMed Valley Discoveries, Inc 5
Early research (Phase 1)Ended earlyNCT04430348
What this trial is testing

PTX-35 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Pelican Therapeutics, Inc. 22
Early research (Phase 1)Study completedNCT04676633
What this trial is testing

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCholangiocarcinoma
Sirnaomics 5
Early research (Phase 1)Study completedNCT02675491
What this trial is testing

Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Advanced Solid Malignant Tumors
Daiichi Sankyo Co., Ltd. 15
Load More Results